IP Library Granted Patent US 11,766,212
Granted Patent B2
US 11,766,212 · App. 17/245,438 · Granted Sep 26, 2023

Systems and methods for evaluating the integrity of a uterine cavity

Inventors: Dominique Filloux (Redwood City, CA); Dave Clapper (Atherton, CA); Eugene Skalnyi (Hillsborough, CA); Akos Toth (Cupertino, CA); Sean Darby (San Jose, CA); Tejas N. Mazmudar (Palo Alto, CA); Estela Hilario (Los Altos, CA)
Assignee: MINERVA SURGICAL, INC.
A61B5/4325A61B5/4836A61B18/042A61B18/1485A61M13/003A61B5/6847A61B2018/0063A61B2018/00214A61B2018/00559A61B2018/00577A61B2018/00863A61B2018/00904A61B2090/064A61M2202/0225A61M2205/3334A61M2210/1433
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,766,212
App. No.
17/245,438
Granted
Sep 26, 2023
Kind
B2
Abstract

A system for accessing a patient's uterine cavity and detecting perforations in the uterus includes an elongated probe having a flow channel extending to a terminal outlet in a distal region of the probe. A fluid source is coupled to the flow channel, and a seal on the probe is positionable in an endocervical canal. The probe may be trans-cervical inserted into the uterine cavity, and a fluid may be introduced through the channel to flow outwardly from the terminal outlet into the uterine cavity. A parameter of said fluid flow is monitored to detect a perforation in the uterus.

Claims (44)

1. A method for positioning an expandable-collapsible energy applicator in a patient's uterine cavity, said method comprising:

introducing an elongated shaft carrying the expandable-collapsible energy applicator through a cervix of the patient into the uterine cavity,

wherein the expandable-collapsible energy applicator is configured to be expanded to a triangular shape within the uterine cavity,

the expandable-collapsible energy applicator having a first distal apex and a second distal apex,

wherein a first flow channel tubing extends along a first lateral side of the expandable-collapsible energy applicator to the first distal apex and a second flow channel tubing extends along a second lateral side of the expandable-collapsible energy applicator to the second distal apex;

introducing a fluid flow into the uterine cavity through the first flow channel tubing to a first distal outlet in the first distal apex and through the second flow channel tubing to a second distal outlet in the second distal apex with the expandable-collapsible energy applicator positioned within the uterine cavity;

monitoring at least one parameter of the fluid flow to detect a perforation in the uterus,

wherein the at least one parameter is selected from a group consisting of fluid flow rate, fluid pressure, and fluid flow volume.

2. The method of claim 1 , wherein the first flow channel tubing and the second flow channel tubing are each in fluid communication with a gas source.

3. The method of claim 1 , wherein the first flow channel tubing is bonded to the first lateral side of the expandable-collapsible energy applicator and the second flow channel tubing is bonded to the second lateral side of the expandable-collapsible energy applicator.

4. The method of claim 1 , wherein the first flow channel tubing is integrated into the first lateral side of the expandable-collapsible energy applicator and the second flow channel tubing is integrated into the second lateral side of the expandable-collapsible energy applicator.

5. The method of claim 1 , wherein the monitoring step includes determining if the fluid flow rate drops below a predetermined minimum threshold level over a predetermined time interval after initiation of the fluid flow to thereby characterize the uterus as not perforated.

6. The method of claim 5 , wherein the predetermined minimum threshold level is between 0.02 slpm and 0.05 slpm.

7. The method of claim 5 , wherein the predetermined time interval is between 1 second and 20 seconds.

8. The method of claim 5 , wherein the monitoring step further includes determining if the fluid flow rate does not drop below the predetermined minimum threshold level over the predetermined time interval after initiation of the fluid flow to thereby characterize the uterus as perforated.

9. The method of claim 1 , wherein the fluid flow introducing step includes utilizing a controller to control and/or monitor the fluid flow.

10. The method of claim 9 , wherein the controller is configured to control the fluid flow at a rate of between 0.01 slpm and 1.0 slpm.

11. A method for positioning an expandable-collapsible energy applicator in a patient's uterine cavity, said method comprising:

introducing an elongated shaft carrying the expandable-collapsible energy applicator through a cervix of the patient into the uterine cavity,

wherein the expandable-collapsible energy applicator is configured to be expanded to a triangular shape within the uterine cavity,

the expandable-collapsible energy applicator having a first distal apex and a second distal apex,

wherein a first enclosed flow channel extends along a first lateral side of the expandable-collapsible energy applicator to the first distal apex and a second enclosed flow channel extends along a second lateral side of the expandable-collapsible energy applicator to the second distal apex;

introducing a fluid flow into the uterine cavity through the first enclosed flow channel to a first distal outlet of the first enclosed flow channel at the first distal apex and through the second enclosed flow channel to a second distal outlet of the first enclosed flow channel at the second distal apex with the expandable-collapsible energy applicator positioned within the uterine cavity;

monitoring at least one parameter of the fluid flow to detect a perforation in the uterus,

wherein the at least one parameter is selected from a group consisting of fluid flow rate, fluid pressure, and fluid flow volume.

12. The method of claim 11 , wherein the first enclosed flow channel includes a wall completely surrounding the first enclosed flow channel extending along the expandable-collapsible energy applicator,

and the second enclosed flow channel includes a wall completely surrounding the second enclosed flow channel extending along the expandable-collapsible energy applicator.

13. The method of claim 12 , wherein the first enclosed flow channel and the second enclosed flow channel are each in fluid communication with a gas source.

14. The method of claim 12 , wherein the wall of the first enclosed flow channel includes one or more apertures extending through the wall of the first enclosed flow channel.

15. The method of claim 14 , wherein the wall of the second enclosed flow channel includes one or more apertures extending through the wall of the second enclosed flow channel.

16. A method for positioning an expandable-collapsible energy applicator in a patient's uterine cavity, said method comprising:

introducing an elongated shaft carrying the expandable-collapsible energy applicator through a cervix of the patient into the uterine cavity,

wherein the expandable-collapsible energy applicator is configured to be expanded to a triangular shape within the uterine cavity,

the expandable-collapsible energy applicator having a first distal apex and a second distal apex,

wherein a first flow channel tubing extends along a first lateral side of the expandable-collapsible energy applicator to the first distal apex and a second flow channel tubing extends along a second lateral side of the expandable-collapsible energy applicator to the second distal apex;

introducing a fluid flow into the uterine cavity through the first flow channel tubing to a first outlet of the first flow channel tubing and through the second flow channel tubing to a second outlet of the second flow channel tubing with the expandable-collapsible energy applicator positioned within the uterine cavity,

wherein the first outlet and the second outlet are positioned along an exterior of the expandable-collapsible energy applicator;

monitoring at least one parameter of the fluid flow to detect a perforation in the uterus,

wherein the at least one parameter is selected from a group consisting of fluid flow rate, fluid pressure, and fluid flow volume.

17. The method of claim 16 , wherein the first flow channel tubing and the second flow channel tubing are each in fluid communication with a gas source.

18. The method of claim 16 , wherein the first flow channel tubing is bonded to the first lateral side of the expandable-collapsible energy applicator and the second flow channel tubing is bonded to the second lateral side of the expandable-collapsible energy applicator.

19. The method of claim 16 , wherein the first flow channel tubing is integrated into the first lateral side of the expandable-collapsible energy applicator and the second flow channel tubing is integrated into the second lateral side of the expandable-collapsible energy applicator.

20. The method of claim 16 , wherein the first flow channel tubing includes a plurality of flow outlets extending through a wall of the first flow channel tubing,

and the second flow channel tubing includes a plurality of flow outlets extending through a wall of the second flow channel tubing.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2026
From: MINERVA SURGICAL, INC.
To: AXORA MEDICAL, INC.
Reel/Frame 075561/0186 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2021
From: FILLOUX, DOMINIQUE; CLAPPER, DAVE; SKALNYI, EUGENE; TOTH, AKOS; DARBY, SEAN; MAZMUDAR, TEJAS N.; HILARIO, ESTELA
To: MINERVA SURGICAL, INC.
Reel/Frame 057299/0318 →
Continuity (5)
Continuation 15954491 · Apr 16, 2018
Continuation In Part PCTUS2018015774 · Jan 29, 2018
Continuation In Part 15418635 · Jan 27, 2017
Provisional Application 62473049 · Mar 17, 2017
Related Publication 20220015689A1 · Jan 20, 2022